U.S. market for polymeric (plastic) foams to grow 8.5 billion pounds by 2015

The U.S. market for polymeric (plastic) foams was about 7.4 billion pounds in 2009 and is expected to reach 7.5 billion pounds in 2010 and 8.5 billion pounds by 2015, a compound annual growth rate (CAGR) of 2.5% over the next 5 years.

Learn about the most important technological, economic, political, and environmental considerations in the U.S. polymeric foams industry and get information on the polymeric foams market by material types and by application along with relevant company profiles...

Use this report to:

• Learn about the significant changes that have occurred in this major segment of the plastics production and processing industry
• Navigate the environmental, regulatory, and public policy issues that are of increasing importance to the polymer foams industry
• Capture your share of newer markets, such as cross-linked polyolefin foam in leisure and sports goods, and foams made from biopolymers and biodegradable polymers to reduce the country’s dependency on petroleum and natural gas
• Formulate business plans based on forecasts for plastic foams of several kindsin many different important markets such as construction, transportation, and packaging.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global market for Musculoskeletal Disease to reach $57 billion by 2014

The global market for Musculoskeletal Disease was about $45 billion in 2009 and is expected to reach $57 billion by 2014, a compound annual growth rate (CAGR) of around 5% from 2009 through 2014.

Learn about the current pipeline of therapeutics and biomaterials utilized in the treatment of Musculoskeletal Diseases (MSDs), analyze the market and forecast for MSD therapeutics and treatments, and outline the key factors that will influence this therapeutic area in the next few years...

Use this report to:

• Assess the growth potential of musculoskeletal disease treatments over a 5-year period and understand the key factors that will influence this therapeutic area
• Learn how advances in biomaterials are being translated into viable products in the orthobiologics area, changing the way a number of related disease states are treated and creating more therapies and market opportunities
• Identify which marketing and distribution partnerships, technology platforms, and product development programs are likely to yield new targets and drugs that will reach the market in the next few years
• Formulate marketing and business plans based on usage projections in the major primary and secondary disease application areas.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global sales of Velcade to reach $3 billion by 2015

The global sales of Velcade (a proteasome inhibitor) was about $1.4 billion in 2009 and is expected to reach $3 billion in 2015, a compound annual growth rate (CAGR) of 13.5% through 2015.

Learn about the current state of drug discovery in the ubiquitin proteasome research field, existing products on the market, and detailed analysis of the competitive environments, including new potential markets for current research projects. This report includes information about significant players in this field of study, trends, and challenges, and other information affecting drug discovery in the ubiquitin proteasome system (UPS)...

Use this report to:

• Understand this emerging area of drug discovery and development
• Learn about the major research trends in UPS that are going to affect further drug development in this area, identification of new drug candidates, and new technologies in assay development
• Develop strategies and tools to evaluate potential commercial opportunities in this new field
• Gain insight into competitors’ positions and which companies are closest to introducing new products to the market in the next couple of years.

To provide further information about this report we offer a Complimentary Introduction, available from our Website.

Global market for ozone technology to reach $821 million by 2015

The global market for ozone technology is expected to reach $557 million in 2010 and $821 million by 2015, a compound annual growth rate (CAGR) of 8.1 % over the next 5 years.

Learn about the global market for ozone treatment in three major categories: water/wastewater disinfection/ozonation, air/gas purification and treatment, and medicine. Get five-year projections for market activity and value, and information on industry structure, technological trends, pricing considerations, R&D, government regulations, company profiles and competitive technologies...

Use this report to:

• Gain a comprehensive view of the ozone generation market with this unique collection of information and conclusions that are difficult to find elsewhere
• Understand how regulations, market pressures, and technology interact in the ozone generation industry and which technical and market influences will drive growth trends over the next 5 years
• Develop business strategies to prepare for the rising popularity of ozone because of dwindling water supplies, lower quality resources, and stricter quality standards
• Make successful, educated decisions regarding investment, acquisition, or expansion into the industry as the need for environmental protection and for repairs to decaying water treatment works speed the pace of investment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website.

Global market for cardiovascular sector worth $139.8 billion by 2015

The overall cardiovascular sector grew to $140.7 billion in 2009, showing a growth rate of 3.1% and is expected to continue to grow in 2010 to $144.5 billion by a compound annual growth rate (CAGR) of 2.7%. The sector will experience a sizable reduction in the early portion of the forecast period, and then slowly rise to a net small reduction by 2015 on a CAGR basis of -0.7%, to a figure of $139.8 billion.

Learn about the overall industry trends in the global market for cardiovascular therapies with current and projected product forecasts through 2015; get detailed product analyses within disease subsegments and an analysis of leading and emerging competitors in this field with relevant company profiles...

Use this report to:

• Identify and understand overall market trends in cardiovascular therapeutics, including emerging geographies, M&A opportunities, and insights that provide guidance for sales growth or defensive moves
• Develop effective strategies to take advantage of product opportunities in this dynamic market as combination and differentiated therapies influence the competitive environment, and key products lose patent protection
• Validate internal marketing and business development plans with quantitative and qualitative forecasts by product, product category, and by company from 2009 through 2015
• Learn about leading and novel products in each core segment of the overall market, their specific mechanisms of action, and their competitive positions.

To provide further information about this report we offer a Complimentary Introduction, available from our Website.
 

U.S. medical plastics market to reach 4.4 billion pounds by 2015

The U.S. medical plastics market was about 3.3 billion pounds in 2009 and is expected to reach 3.5 billion pounds in 2010 and 4.4 billion pounds by 2015, a compound annual growth rate (CAGR) of 4.9% over the next 5 years.

Learn about the medical device industry, the key resins used to make these devices, legislative/regulatory and environmental issues, new products and technologies related to medical devices and various applications of medical plastics...

Use this report to:

• Prepare for the many conflicting and critical issues confronting the industry that will significantly affect its growth and demand for its plastic products
• Learn about strategies to contain costs and avoid increasingly stringent regulatory obstacles in the U.S., such as developing and marketing products in Europe, and forming partnerships, joint ventures, purchasing groups, and other types of cooperative alliances with resin suppliers
• Formulate business strategies based on influential market factors such as shifts in plastic usage, healthcare cost containment pressures, environmental issues regarding disposal of medical device plastics, and trends in contract manufacturing and outsourcing
• Understand how new products and technologies related to medical devices, changing sterilization techniques, and trends polymer usage in medical devices are shaping this dynamic industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. 
 

Global market for diabetes therapies and diagnostics worth $51.2 billion by 2015

The global market for diabetes therapies and diagnostics was about $35.5 billion in 2009 and is expected to reach $38 billion in 2010 and $51.2 billion by 2015, a compound annual growth rate (CAGR) of 6.1% over the next 5 years.


Learn about the important trends in the global market for diabetes therapies and diagnostics. Get sales forecasts by product categories and major country markets through 2015 plus information on R&D trends and differential market potential on a country-by-country basis. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity...

Use this report to:

• Understand the current extent of the diabetes epidemic, its likely evolution over the next 5 years, and the impact of drugs and technical developments now in the pipeline
• Quantify and qualify the market for prescription branded and generic drugs used to treat diabetes as well as devices and instruments used to diagnose and monitor diabetes
• Formulate business and marketing strategies based on sales forecasts by product categories, epidemiological data and projections, R&D trends, and differential market potential on a country-by-country basis.
• Learn about the key issues influencing this field, such as healthcare policies, demographics, and the wider economic environment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.